7357 TR for Sale
AA WATER High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Dula-10, factory-direct high-quality peptides, white dry powder, competitive pricing, in-stock available
-
Price:
$190/MT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
BAC WATER High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
B12 High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
TT10, factory-direct high-quality peptides, white dry powder, competitive pricing, in-stock available
-
Price:
$200/MT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg*10vials/box
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
Products You May Be Interested in
LEMON BOTTLE High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
GGH High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
SHR High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
GAZ High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
LMX High Purity Research Synthetic Peptide Raw Material Bulk From China Supplier
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99.976%
-
Packaging:
10mg x 10ml/vial
Tirzepatide,Retatrutide,GHK-CU,KPV,MOTS-C,KLOW80,Cartalax,NAD+,Selank,Semax
- Finding TR for sale in large quantity of choices all on www.echemi.com. The suppliers of 7357 TR on the search result are been verified by the accurate information of each one. To make sure the safety of the transaction on ECHEMI, we will make sure the information is trust-worthy of each supplier. Buy TR with 70000+ customers on ECHEMI and make orders now.
- We guarantee the quality of TR 2026000-20-2 on ECHEMI. Our business partners are with certification, quanlification and so on. We help buyers to get TR with various requirement and regulations in global countries and regions. Customized services of TR will provided to customers on ECHEMI.
- TR in reasonable and fair market price will be provided with better options and services. Member registered on ECHEMI will enjoy services of TR for example market price and insights and trade data. You can enjoy the chemical supply chain services on ECHEMI. ECHEMI is helping you of TR with global procurement service.
- •Cost-Driven Acrylonitrile Market Halts Decline and Stabilizes
- •In August, the domestic propylene oxide market showed an upward trend in price levels
- •Business Society’s Market Outlook for n-Butanol on September 4, 2026: Fluctuating Trend
- •September 4, 2026 DMF Market View in China: Relatively Strong
- •Business Society’s September 4, 2026 Melamine Market Outlook: Fluctuating Trend